Delhivery Ltd

  • BSE Code : 543529
  • NSE Symbol : DELHIVERY
  • ISIN : INE148O01028
  • Industry :MISCELLANEOUS

up-arrow 429.85 4.60(1.08%)

Open Price ()

427.00

Prev. Close ()

425.25

Volume (No’s)

3,932,117

Market Cap ()

32,092.26

Low Price ()

424.50

High Price ()

437.75

 

Board Meetings

Start Date End Date Purpose
25-Jul-2025 01-Aug-2025 Delhivery Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2025 Financial Results for the quarter ended June 30, 2025 Intimation for the appointment of Dr. Padmini Srinivasan and Mr. Yashish Dahiya as Non- Executive Independent Directors of the Company (As per BSE Announcement Dated on 01/08/2025)
09-May-2025 16-May-2025 Delhivery Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 inter alia to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31 2025. Financial Results for the Quarter and Financial Year Ended March 31, 2025 (As Per BSE Announcement Dated on: 16/05/2025)
05-Apr-2025 05-Apr-2025 Delhivery to acquire Ecom Express Limited
31-Jan-2025 07-Feb-2025 Delhivery Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve To consider and approve inter alia Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2024 Financial results for the quarter and nine months ended Dec 31, 2024 Appointment of Mr. Sameer Mehta as Non Executive Independent Director of the Company Appointment of Ms. Namita Thapar as Non-Executive Independent Director of the Company (As per BSE Announcement Dated on 07/02/2025) In continuation to the press release and disclosure submitted under Regulation 30 on Feb 7, 2025, we wish to clarify that inadvertently in Ms. Namita Thapar''s profile, it was mentioned that she is the executive Director and CEO of India Business of Emcure Pharmaceuticals Limited. Please note that she is the whole-time director of Emcure Pharmaceuticals Limited and heading its India business. (As Per BSE Announcement Dated on 08/02/2025)
07-Nov-2024 14-Nov-2024 Delhivery Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30 2024. Financials results for the quarter and half year ended September 30, 2024 (As per BSE Announcement Dated on 14/11/2024)

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew